Revelation Biosciences (REVB) Q1 2026 Earnings

26FebConfirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-20.64
-14.31
-7.98
-1.65

Details

Expected EPS
-3.66
Actual EPS
-1.65
Surprise EPS
2.01
Surprise Percent
+54.92%

Description

Revelation Biosciences (REVB) has reported earnings of -1.65 per share for Q1 2026.

0 Comments

Share your thoughts